Dent Mater J:正畸托槽粘接前的渗透树脂和CPP-ACP应用效果评估

2019-08-29 lishiting MedSci原创

这篇研究的目的是为了评估酪蛋白磷酸肽-无定形磷酸钙(CPP-ACP)凝胶和渗透树脂对脱钙釉质的影响,并探讨离子释放和剪切粘接强度(SBS)之间可能的相关性。

这篇研究的目的是为了评估酪蛋白磷酸肽-无定形磷酸钙(CPP-ACP)凝胶和渗透树脂对脱钙釉质的影响,并探讨离子释放和剪切粘接强度(SBS)之间可能的相关性。

研究共使用80颗前磨牙作为实验对象(n=20)。组I为对照组,而其他组均进行牙齿脱矿。CPP-ACP凝胶和渗透树脂分别应用于组III和IV。在脱矿前后,所有组以及药物应用后的组III和IV进行能量色散x射线分析。研究也进行SBS测试。

结果显示,药物应用后的Ca/P比例显著升高。2个药物组的SBS比其他组均明显下降。SBS和Ca/P比例变化之间无明显的相关性。可以说,CPP-ACP和渗透树脂疗法能够增加牙齿的矿物质含量,但是SBS值比对照组和仅脱矿组明显降低。

原始出处:

Gulec A, Goymen M, et al. Assessment of the resin infiltration and CPP-ACP applications before orthodontic brackets bonding. Dent Mater J. 2019 Aug 22. doi: 10.4012/dmj.2019-021.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1991698, encodeId=b646199169837, content=<a href='/topic/show?id=e22551e681' target=_blank style='color:#2F92EE;'>#CPP-ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5176, encryptionId=e22551e681, topicName=CPP-ACP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Wed Jul 22 18:16:00 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006913, encodeId=a04b2006913ef, content=<a href='/topic/show?id=f2536629845' target=_blank style='color:#2F92EE;'>#渗透树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66298, encryptionId=f2536629845, topicName=渗透树脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon May 11 04:16:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746534, encodeId=06fd1e4653456, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jun 18 19:16:00 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890933, encodeId=5a96189093364, content=<a href='/topic/show?id=84505e5207c' target=_blank style='color:#2F92EE;'>#效果评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57520, encryptionId=84505e5207c, topicName=效果评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Apr 28 23:16:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361701, encodeId=352b1361e0127, content=<a href='/topic/show?id=4fb763256d4' target=_blank style='color:#2F92EE;'>#正畸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63256, encryptionId=4fb763256d4, topicName=正畸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627598, encodeId=9fab162e5980d, content=<a href='/topic/show?id=cea46199eba' target=_blank style='color:#2F92EE;'>#树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61997, encryptionId=cea46199eba, topicName=树脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378b21121654, createdName=chenshujs, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046897, encodeId=146d104689efa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu Aug 29 18:16:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371968, encodeId=77ac3e196813, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Aug 29 17:10:28 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
    2020-07-22 xfpan12
  2. [GetPortalCommentsPageByObjectIdResponse(id=1991698, encodeId=b646199169837, content=<a href='/topic/show?id=e22551e681' target=_blank style='color:#2F92EE;'>#CPP-ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5176, encryptionId=e22551e681, topicName=CPP-ACP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Wed Jul 22 18:16:00 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006913, encodeId=a04b2006913ef, content=<a href='/topic/show?id=f2536629845' target=_blank style='color:#2F92EE;'>#渗透树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66298, encryptionId=f2536629845, topicName=渗透树脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon May 11 04:16:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746534, encodeId=06fd1e4653456, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jun 18 19:16:00 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890933, encodeId=5a96189093364, content=<a href='/topic/show?id=84505e5207c' target=_blank style='color:#2F92EE;'>#效果评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57520, encryptionId=84505e5207c, topicName=效果评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Apr 28 23:16:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361701, encodeId=352b1361e0127, content=<a href='/topic/show?id=4fb763256d4' target=_blank style='color:#2F92EE;'>#正畸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63256, encryptionId=4fb763256d4, topicName=正畸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627598, encodeId=9fab162e5980d, content=<a href='/topic/show?id=cea46199eba' target=_blank style='color:#2F92EE;'>#树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61997, encryptionId=cea46199eba, topicName=树脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378b21121654, createdName=chenshujs, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046897, encodeId=146d104689efa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu Aug 29 18:16:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371968, encodeId=77ac3e196813, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Aug 29 17:10:28 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1991698, encodeId=b646199169837, content=<a href='/topic/show?id=e22551e681' target=_blank style='color:#2F92EE;'>#CPP-ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5176, encryptionId=e22551e681, topicName=CPP-ACP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Wed Jul 22 18:16:00 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006913, encodeId=a04b2006913ef, content=<a href='/topic/show?id=f2536629845' target=_blank style='color:#2F92EE;'>#渗透树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66298, encryptionId=f2536629845, topicName=渗透树脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon May 11 04:16:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746534, encodeId=06fd1e4653456, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jun 18 19:16:00 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890933, encodeId=5a96189093364, content=<a href='/topic/show?id=84505e5207c' target=_blank style='color:#2F92EE;'>#效果评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57520, encryptionId=84505e5207c, topicName=效果评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Apr 28 23:16:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361701, encodeId=352b1361e0127, content=<a href='/topic/show?id=4fb763256d4' target=_blank style='color:#2F92EE;'>#正畸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63256, encryptionId=4fb763256d4, topicName=正畸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627598, encodeId=9fab162e5980d, content=<a href='/topic/show?id=cea46199eba' target=_blank style='color:#2F92EE;'>#树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61997, encryptionId=cea46199eba, topicName=树脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378b21121654, createdName=chenshujs, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046897, encodeId=146d104689efa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu Aug 29 18:16:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371968, encodeId=77ac3e196813, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Aug 29 17:10:28 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
    2020-06-18 waiwai3042
  4. [GetPortalCommentsPageByObjectIdResponse(id=1991698, encodeId=b646199169837, content=<a href='/topic/show?id=e22551e681' target=_blank style='color:#2F92EE;'>#CPP-ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5176, encryptionId=e22551e681, topicName=CPP-ACP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Wed Jul 22 18:16:00 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006913, encodeId=a04b2006913ef, content=<a href='/topic/show?id=f2536629845' target=_blank style='color:#2F92EE;'>#渗透树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66298, encryptionId=f2536629845, topicName=渗透树脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon May 11 04:16:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746534, encodeId=06fd1e4653456, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jun 18 19:16:00 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890933, encodeId=5a96189093364, content=<a href='/topic/show?id=84505e5207c' target=_blank style='color:#2F92EE;'>#效果评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57520, encryptionId=84505e5207c, topicName=效果评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Apr 28 23:16:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361701, encodeId=352b1361e0127, content=<a href='/topic/show?id=4fb763256d4' target=_blank style='color:#2F92EE;'>#正畸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63256, encryptionId=4fb763256d4, topicName=正畸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627598, encodeId=9fab162e5980d, content=<a href='/topic/show?id=cea46199eba' target=_blank style='color:#2F92EE;'>#树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61997, encryptionId=cea46199eba, topicName=树脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378b21121654, createdName=chenshujs, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046897, encodeId=146d104689efa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu Aug 29 18:16:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371968, encodeId=77ac3e196813, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Aug 29 17:10:28 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1991698, encodeId=b646199169837, content=<a href='/topic/show?id=e22551e681' target=_blank style='color:#2F92EE;'>#CPP-ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5176, encryptionId=e22551e681, topicName=CPP-ACP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Wed Jul 22 18:16:00 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006913, encodeId=a04b2006913ef, content=<a href='/topic/show?id=f2536629845' target=_blank style='color:#2F92EE;'>#渗透树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66298, encryptionId=f2536629845, topicName=渗透树脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon May 11 04:16:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746534, encodeId=06fd1e4653456, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jun 18 19:16:00 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890933, encodeId=5a96189093364, content=<a href='/topic/show?id=84505e5207c' target=_blank style='color:#2F92EE;'>#效果评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57520, encryptionId=84505e5207c, topicName=效果评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Apr 28 23:16:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361701, encodeId=352b1361e0127, content=<a href='/topic/show?id=4fb763256d4' target=_blank style='color:#2F92EE;'>#正畸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63256, encryptionId=4fb763256d4, topicName=正畸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627598, encodeId=9fab162e5980d, content=<a href='/topic/show?id=cea46199eba' target=_blank style='color:#2F92EE;'>#树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61997, encryptionId=cea46199eba, topicName=树脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378b21121654, createdName=chenshujs, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046897, encodeId=146d104689efa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu Aug 29 18:16:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371968, encodeId=77ac3e196813, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Aug 29 17:10:28 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
    2019-08-31 grace5700
  6. [GetPortalCommentsPageByObjectIdResponse(id=1991698, encodeId=b646199169837, content=<a href='/topic/show?id=e22551e681' target=_blank style='color:#2F92EE;'>#CPP-ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5176, encryptionId=e22551e681, topicName=CPP-ACP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Wed Jul 22 18:16:00 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006913, encodeId=a04b2006913ef, content=<a href='/topic/show?id=f2536629845' target=_blank style='color:#2F92EE;'>#渗透树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66298, encryptionId=f2536629845, topicName=渗透树脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon May 11 04:16:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746534, encodeId=06fd1e4653456, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jun 18 19:16:00 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890933, encodeId=5a96189093364, content=<a href='/topic/show?id=84505e5207c' target=_blank style='color:#2F92EE;'>#效果评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57520, encryptionId=84505e5207c, topicName=效果评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Apr 28 23:16:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361701, encodeId=352b1361e0127, content=<a href='/topic/show?id=4fb763256d4' target=_blank style='color:#2F92EE;'>#正畸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63256, encryptionId=4fb763256d4, topicName=正畸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627598, encodeId=9fab162e5980d, content=<a href='/topic/show?id=cea46199eba' target=_blank style='color:#2F92EE;'>#树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61997, encryptionId=cea46199eba, topicName=树脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378b21121654, createdName=chenshujs, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046897, encodeId=146d104689efa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu Aug 29 18:16:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371968, encodeId=77ac3e196813, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Aug 29 17:10:28 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
    2019-08-31 chenshujs
  7. [GetPortalCommentsPageByObjectIdResponse(id=1991698, encodeId=b646199169837, content=<a href='/topic/show?id=e22551e681' target=_blank style='color:#2F92EE;'>#CPP-ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5176, encryptionId=e22551e681, topicName=CPP-ACP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Wed Jul 22 18:16:00 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006913, encodeId=a04b2006913ef, content=<a href='/topic/show?id=f2536629845' target=_blank style='color:#2F92EE;'>#渗透树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66298, encryptionId=f2536629845, topicName=渗透树脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon May 11 04:16:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746534, encodeId=06fd1e4653456, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jun 18 19:16:00 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890933, encodeId=5a96189093364, content=<a href='/topic/show?id=84505e5207c' target=_blank style='color:#2F92EE;'>#效果评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57520, encryptionId=84505e5207c, topicName=效果评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Apr 28 23:16:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361701, encodeId=352b1361e0127, content=<a href='/topic/show?id=4fb763256d4' target=_blank style='color:#2F92EE;'>#正畸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63256, encryptionId=4fb763256d4, topicName=正畸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627598, encodeId=9fab162e5980d, content=<a href='/topic/show?id=cea46199eba' target=_blank style='color:#2F92EE;'>#树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61997, encryptionId=cea46199eba, topicName=树脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378b21121654, createdName=chenshujs, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046897, encodeId=146d104689efa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu Aug 29 18:16:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371968, encodeId=77ac3e196813, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Aug 29 17:10:28 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
    2019-08-29 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1991698, encodeId=b646199169837, content=<a href='/topic/show?id=e22551e681' target=_blank style='color:#2F92EE;'>#CPP-ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5176, encryptionId=e22551e681, topicName=CPP-ACP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Wed Jul 22 18:16:00 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006913, encodeId=a04b2006913ef, content=<a href='/topic/show?id=f2536629845' target=_blank style='color:#2F92EE;'>#渗透树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66298, encryptionId=f2536629845, topicName=渗透树脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon May 11 04:16:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746534, encodeId=06fd1e4653456, content=<a href='/topic/show?id=df4e18e4fc' target=_blank style='color:#2F92EE;'>#ACP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1874, encryptionId=df4e18e4fc, topicName=ACP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=234435772502, createdName=waiwai3042, createdTime=Thu Jun 18 19:16:00 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1890933, encodeId=5a96189093364, content=<a href='/topic/show?id=84505e5207c' target=_blank style='color:#2F92EE;'>#效果评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57520, encryptionId=84505e5207c, topicName=效果评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Tue Apr 28 23:16:00 CST 2020, time=2020-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361701, encodeId=352b1361e0127, content=<a href='/topic/show?id=4fb763256d4' target=_blank style='color:#2F92EE;'>#正畸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63256, encryptionId=4fb763256d4, topicName=正畸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627598, encodeId=9fab162e5980d, content=<a href='/topic/show?id=cea46199eba' target=_blank style='color:#2F92EE;'>#树脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61997, encryptionId=cea46199eba, topicName=树脂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=378b21121654, createdName=chenshujs, createdTime=Sat Aug 31 06:16:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046897, encodeId=146d104689efa, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Thu Aug 29 18:16:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=371968, encodeId=77ac3e196813, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Thu Aug 29 17:10:28 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
    2019-08-29 130****4638

    学习了,谢谢分享

    0

相关资讯

Dent Mater J:采用渗透树脂和微打磨处理发育性釉质缺陷色泽改变的效果比较

这篇研究的目的是为了评估比较使用渗透树脂与微打磨后应用2种再矿化材料治疗发育性釉质缺陷前牙的色泽遮盖效果。